Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1931 studies found for:    "Pancreatic cancer"
Show Display Options
Rank Status Study
21 Completed Phase 2 Study of Erlotinib, Gemcitabine and Oxaliplatin Combination Chemotherapy to Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Erlotinib;   Drug: Gemcitabine;   Drug: Oxaliplatin
22 Active, not recruiting Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Biological: bevacizumab;   Drug: fluorouracil;   Drug: gemcitabine hydrochloride;   Drug: oxaliplatin;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Procedure: conventional surgery;   Procedure: endoscopic biopsy;   Procedure: laparoscopy;   Radiation: radiation therapy
23 Completed Vaccine Study for Surgically Resected Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Biological: HyperAcute(R)-Pancreatic Cancer Vaccine
24 Not yet recruiting Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy
Condition: Pancreatic Cancer
Intervention:
25 Recruiting Evaluation of Prognosis With Integrated MRI/PET in Patients With Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Device: The imaging biomarkers determined by MR-PET
26 Terminated Low Dose Vaccine Study for Surgically Resected Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Biological: HyperAcute(R)-Pancreatic Cancer Vaccine
27 Unknown  Integrated Positron Emission Tomography - Computed Tomography (PET-CT) in Patients With Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention:
28 Completed Immunotherapy Study for Surgically Resected Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Biological: HyperAcute-Pancreas Immunotherapy;   Drug: Gemcitabine;   Radiation: 5FU Chemoradiation
29 Completed Opioid Growth Factor in Treating Patients With Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
Condition: Pancreatic Cancer
Interventions: Biological: opioid growth factor;   Biological: metenkephalin, OGF-opioid growth factor
30 Completed Studying Biomarkers in Patients With Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Genetic: protein analysis;   Other: laboratory biomarker analysis
31 Completed
Has Results
RAD001 in Previously Treated Patients With Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: RAD001
32 Withdrawn HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Procedure: interventional therapy
33 Completed Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: paclitaxel-loaded polymeric micelle
34 Active, not recruiting A Clinical Research About Using Irreversible Electroporation to Treat Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Device: Irreversible Electroporation (IRE) System
35 Recruiting Pancreatic Cancer Genetics
Condition: Pancreatic Cancer
Intervention:
36 Active, not recruiting Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: Hydroxychloroquine
37 Completed Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Genetic: polymorphism analysis;   Other: immunologic technique;   Other: laboratory biomarker analysis;   Other: medical chart review
38 Withdrawn Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Biological: bleomycin sulfate;   Drug: electroporation therapy
39 Completed IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Gefitinib;   Drug: Gemcitabine
40 Completed
Has Results
Abraxane Therapy in Patients With Pancreatic Cancer Who Failed First-Line Gemcitabine Therapy
Condition: Pancreatic Cancer
Intervention: Drug: Abraxane

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.